| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
61,413,000 |
| Market
Cap: |
8.67(B) |
| Last
Volume: |
854,657 |
Avg
Vol: |
504,733 |
| 52
Week Range: |
$114.17 - $208.42 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Repligen is a life sciences company that develops and commercializes bioprocessing technologies and systems used in the process of manufacturing biological drugs. Co.'s bioprocessing business is comprised of:Filtration, which includes XCell Alternating Tangential Flow systems that are used in upstream perfusion cell culture processing; Chromatography, which includes products used in downstream purification, development, manufacturing and quality control of biological drugs; Process Analytics, which complements and supports its Filtration, Chromatography and Proteins franchises; and Proteins, which are represented by its Protein A affinity ligands and cell culture growth factor products.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
1,500 |
| Total Buy Value |
$0 |
$0 |
$0 |
$238,260 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
3 |
| Total Shares Sold |
23,589 |
45,669 |
50,307 |
151,828 |
| Total Sell Value |
$4,058,631 |
$8,416,817 |
$9,119,818 |
$30,980,273 |
| Total People Sold |
2 |
4 |
5 |
6 |
| Total Sell Transactions |
2 |
5 |
7 |
17 |
| End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Hunt Anthony |
Chief Executive Officer |
• – – |
2016-05-05 |
4 |
D |
$25.71 |
$41,702 |
D/D |
(1,622) |
73,342 |
|
- |
|
| Rusche James R |
Senior Vice President |
• – – |
2016-02-29 |
4 |
D |
$26.05 |
$36,965 |
D/D |
(1,419) |
100,516 |
|
- |
|
| Snodgres Jon |
CFO |
• – – |
2016-02-29 |
4 |
D |
$26.05 |
$19,485 |
D/D |
(748) |
17,777 |
|
- |
|
| Benjamin Howard |
VP Business Development |
• – – |
2016-02-29 |
4 |
D |
$26.05 |
$33,917 |
D/D |
(1,302) |
21,515 |
|
- |
|
| Hunt Anthony |
Chief Executive Officer |
• – – |
2016-02-29 |
4 |
D |
$26.05 |
$59,055 |
D/D |
(2,267) |
74,964 |
|
- |
|
| Rusche James R |
Senior Vice President |
• – – |
2016-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
5,086 |
101,935 |
|
- |
|
| Snodgres Jon |
CFO |
• – – |
2016-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
7,905 |
18,525 |
|
- |
|
| Benjamin Howard |
VP Business Development |
• – – |
2016-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
6,263 |
22,817 |
|
- |
|
| Hunt Anthony |
Chief Executive Officer |
• – – |
2016-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
33,589 |
77,231 |
|
- |
|
| Benjamin Howard |
VP Business Development |
– – – |
2015-11-19 |
4 |
OE |
$3.33 |
$16,650 |
D/D |
5,000 |
16,554 |
|
- |
|
| Dawes Karen A |
Director |
– • – |
2015-11-10 |
4 |
A |
$26.70 |
$26,700 |
D/D |
1,000 |
40,241 |
|
- |
|
| Cooper Glenn L Md |
Director |
– • – |
2015-11-09 |
4 |
A |
$26.56 |
$26,564 |
D/D |
1,000 |
35,331 |
|
- |
|
| Snodgres Jon |
Chief Financial Officer |
• – – |
2015-07-14 |
4 |
D |
$41.30 |
$13,423 |
D/D |
(325) |
10,620 |
|
- |
|
| Hunt Anthony |
Chief Executive Officer |
• – – |
2015-06-12 |
4 |
D |
$38.46 |
$62,498 |
D/D |
(1,625) |
43,642 |
|
- |
|
| Benjamin Howard |
VP Business Development |
– – – |
2015-06-09 |
4 |
S |
$37.48 |
$288,486 |
D/D |
(7,697) |
11,554 |
|
- |
|
| Benjamin Howard |
VP Business Development |
– – – |
2015-06-08 |
4 |
S |
$38.32 |
$1,046,368 |
D/D |
(27,303) |
19,251 |
|
- |
|
| Ryan Thomas F Jr |
Director |
– • – |
2015-05-29 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,000 |
20,331 |
|
- |
|
| Goldberg Alfred Lewis |
Director |
– • – |
2015-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
1,019 |
40,331 |
|
- |
|
| Cox John |
Director |
– • – |
2015-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
1,858 |
1,858 |
|
- |
|
| Dawes Karen A |
Director |
– • – |
2015-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
1,498 |
39,241 |
|
- |
|
| Barthelemy Nicholas |
Director |
– • – |
2015-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
1,019 |
1,019 |
|
- |
|
| Cooper Glenn L Md |
Director |
– • – |
2015-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
1,019 |
34,331 |
|
- |
|
| Ryan Thomas F Jr |
Director |
– • – |
2015-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
1,019 |
21,331 |
|
- |
|
| Rusche James R |
Senior Vice President |
• – – |
2015-05-15 |
4 |
S |
$41.32 |
$619,833 |
D/D |
(15,000) |
96,849 |
|
- |
|
| Herlihy Walter C |
PRESIDENT, CEO |
• • – |
2015-05-12 |
4 |
S |
$38.97 |
$1,770,332 |
D/D |
(45,431) |
262,430 |
|
- |
|
647 Records found
|
|
Page 17 of 26 |
|
|
4.55 (3.12%) 
